Investing Profile

Jack Kenney(5)

VCInvestor
Associate at SV Health Investors
svhealthinvestors.comBoston, Massachusetts
Photo of Jack Kenney, Associate at SV Health Investors
University of Notre Dame Network
26 CONNECTIONS
University of Notre Dame Network
26 CONNECTIONS
cb
$30K - $3.0M
$1.5M
5
£200M
CompanyStageDateRound SizeTotal Raised
Xilio Therapeutics
Series BMar 2020$100M
$330M
Co-investors: Peter Dudek (MRL Ventures Fund), Mike Ross (SV Health Investors), Jayson Punwani (Abingworth), Nancy Hong (RiverVest), Andrew Hack (Bain Capital Life Sciences)
Cellinta
SeedFeb 2020$5M
$5M
Catamaran Bio
SeedJan 2020$4.5M
$47M
Co-investors: Houman Ashrafian (SV Health Investors), Maina Bhaman (Soffinova Partners), Caroline Gaynor (Lightstone Ventures)
Caraway Therapeutics
Series ANov 2018$23M
$46M
Co-investors: Reza Halse (RA Capital), John Gustofson (AbbVie Ventures)
Pionyr Immunotherapeutics
Series AJan 2017$8.5M
$79M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Michael Powell (Omega Funds), Leon Chen (The Column Group), Arjun Goyal (Vida Ventures)
Companies developing medicines to treat, modify, or cure severe diseases, including cancer, neurodegeneration, genetic disease, infection, and other medical needs. We seek companies positioned to outperform due to world-class management, innovative science, and competitive differentiation.
Analyst Estuary Capital Management, LP2022 - Present
Senior Associate SV Health Investors2021 - 2022
Associate SV Health Investors2019 - 2021
Analyst SV Health Investors2019 - 2019
Senior Analyst ClearView Healthcare Partners2018 - 2019
Analyst ClearView Healthcare Partners2017 - 2018
College of the Holy Cross A.B. Chemistry, Economics
University of Notre Dame M.S. Engineering, Science & Technology Entrepreneurship
University of Notre Dame Master of Science (M.S.)
College of the Holy Cross Bachelor of Arts (A.B.)